Viewing Study NCT01921335

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:41 PM
Ignite Modification Date: 2026-05-15 @ 3:40 PM
Study NCT ID: NCT01921335
Status: COMPLETED
Last Update Posted: 2024-11-06
First Post: 2013-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: ARRY-380 + Trastuzuamab for Breast w/ Brain Mets
Sponsor: Dana-Farber Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain Metastases From HER2 and Breast Cancer View
None Advanced HER2-positive Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ARRY-380 View
None Trastuzumab View
None Advanced HER2-positive breast cancer View